How this fund's holdings score on the six lenses, weighted by holding weight — plus what the manager is actively buying and selling. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
What's a “leader”? A holding that ranks in the top two deciles (D9 / D10) of its size cohort on BOTH active conviction lenses — Technical and Flow. Leadership-breadth is the share of the fund's weight sitting in those leaders.
Risk & return
Compound returns and the risk taken to earn them, from the fund's own NAV history.
| Sector | 29 Mar | 06 Apr | 04 May | 26 Jun | 06 Jul | 11 Jul | Δ |
|---|---|---|---|---|---|---|---|
| Consumer Durables | 17.3 | 17.3 | 16.4 | 15.3 | 15.3 | 15.3 | -2.1 |
| Automobile | 15.5 | 15.5 | 15.3 | 14.4 | 14.4 | 14.4 | -1.1 |
| Chemicals | 11.2 | 11.2 | 11.5 | 10.5 | 10.5 | 10.5 | -0.7 |
| Capital Goods | 9.4 | 9.4 | 9.0 | 9.7 | 9.7 | 9.7 | +0.2 |
| Pharma | 7.8 | 7.8 | 8.0 | 7.4 | 7.4 | 7.4 | -0.5 |
| Infrastructure | 6.7 | 6.7 | 6.5 | 7.1 | 7.1 | 7.1 | +0.4 |
| FMCG | 7.1 | 7.1 | 7.0 | 6.2 | 6.2 | 6.2 | -1.0 |
| Financial Services | 5.4 | 5.4 | 5.7 | 5.8 | 5.8 | 5.8 | +0.4 |
| Metal | 4.3 | 4.3 | 4.4 | 4.2 | 4.2 | 4.2 | -0.2 |
| IT | 2.4 | 2.4 | 2.3 | 2.1 | 2.1 | 2.1 | -0.3 |
| Healthcare | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | +0.0 |
| Digital | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | -0.1 |
| Other (5) | 3.8 | 3.8 | 3.8 | 3.5 | 3.5 | 3.5 | -0.3 |
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
—
—
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| KIRLOSENG | Infrastructure | 3.95% | 10 | 7 | 8 | 3 | 1 | 1/2 | +61.3% |
| WELCORP | Metal | 2.56% | 9 | 7 | 9 | 9 | 3 | 1/2 | +63.3% |
| JUBLINGREA | Chemicals | 2.45% | 6 | 3 | 5 | 10 | 5 | 0/2 | +7.1% |
| LTFOODS | FMCG | 2.14% | 3 | 6 | 9 | 7 | 9 | 0/2 | -8.6% |
| ECLERX | IT | 1.82% | 3 | 10 | 7 | 4 | 7 | 0/2 | +0.6% |
| IPCALAB | Pharma | 1.74% | 10 | 6 | 1 | 8 | 4 | 1/2 | +18.3% |
| GLAND | Pharma | 1.61% | 9 | 8 | 6 | 6 | 4 | 0/2 | +38.5% |
| ATUL | Chemicals | 1.51% | 3 | 6 | 1 | 9 | 7 | 0/2 | -7.4% |
| CYIENT | Digital | 1.48% | 1 | 2 | 10 | 9 | 9 | 0/2 | -12.0% |
| TECHNOE | Infrastructure | 1.47% | 1 | 8 | 5 | 4 | 7 | 0/2 | -9.6% |
| RRKABEL | Capital Goods | 1.45% | 8 | 9 | 3 | 5 | 4 | 0/2 | +54.7% |
| PNBHOUSING | Financial Services | 1.43% | 9 | 8 | 9 | 9 | 9 | 1/2 | +22.1% |
| NAVINFLUOR | Chemicals | 1.40% | 9 | 10 | 3 | 9 | 1 | 0/2 | +21.1% |
| VTL | Consumer Durables | 1.20% | 7 | 3 | 3 | 4 | 8 | 0/2 | +9.6% |
| RAINBOW | Healthcare | 1.16% | 10 | 7 | 2 | 5 | 4 | 1/2 | +15.3% |
| MFSL | Financial Services | 1.02% | 4 | 1 | 6 | 5 | 4 | 0/2 | -8.0% |
| APARINDS | Capital Goods | 0.98% | 7 | 7 | 3 | 2 | 3 | 0/2 | +20.8% |
| AMBER | Consumer Durables | 0.95% | 5 | 2 | 10 | 5 | 2 | 0/2 | +1.6% |
| BAYERCROP | Chemicals | 0.95% | 2 | 4 | — | 4 | 8 | 0/2 | -17.5% |
| ERIS | Pharma | 0.94% | 5 | 7 | 5 | 6 | 6 | 0/2 | +1.0% |
| NIVABUPA | Financial Services | 0.80% | 8 | — | 1 | 10 | 4 | 0/2 | +13.1% |
| SONACOMS | Automobile | 0.77% | 9 | 8 | 6 | 5 | 1 | 0/2 | +17.7% |
| CONCORDBIO | Pharma | 0.76% | 5 | 4 | 2 | 1 | 4 | 0/2 | +19.8% |
| ANANDRATHI | Capital Markets | 0.76% | 10 | 9 | 6 | 2 | 1 | 0/2 | +13.8% |
| NH | Healthcare | 0.74% | 9 | 8 | 8 | 2 | 3 | 0/2 | +10.3% |
| KPIL | Infrastructure | 0.64% | 8 | 6 | 10 | 6 | 7 | 0/2 | +10.8% |
| MANAPPURAM | Financial Services | 0.59% | 10 | 7 | 7 | 7 | 8 | 1/2 | +20.9% |
| ANGELONE | Capital Markets | 0.58% | 8 | 3 | 7 | 9 | 4 | 0/2 | +18.1% |
| CANHLIFE | Financial Services | 0.48% | 5 | 2 | 4 | 8 | 2 | 0/2 | -5.7% |
| GRAPHITE | Capital Goods | 0.44% | 3 | 3 | 1 | 8 | 6 | 0/2 | -12.3% |
| ENGINERSIN | Infrastructure | 0.38% | 9 | 10 | 2 | 3 | 7 | 0/2 | +7.7% |
Performance · 5.0y
Over the last 5.0 years ₹100 in the fund grew to ₹227 (+127%), vs ₹169 for Nifty 500 (+69%) and ₹152 for Nifty 50 (+52%). Its relative-strength line ended at 149 vs Nifty 50 and 134 vs Nifty 500 — above 100, sustained outperformance.